Valuation
- Market cap
- 392,626,000
- Revenue TTM
- $268,770,000
- Net income TTM
- $-68,110,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -25.34%
- Debt to equity
- 0.68
Trading
- Volume
- 13,800
- Avg volume
- 50,748
- Day's range
- $8.12 – $8.42
- Shares out
- 48,057,000
- Stochastic %K
- 4%
- Beta
- 1.88
- Analysts
- Strong Buy
- Price target
- $45.00
Company profile
Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vire...
Show more
Vireo Growth Inc. operates as a cannabis company that cultivates, manufactures, processes, and distributes medical and adult-use cannabis products in Maryland, Minnesota, Missouri, Nevada, New York, and Utah. It sells cannabis products through a network of retail dispensaries and distributors. The company was formerly known as Goodness Growth Holdings, Inc. and changed its name to Vireo Growth Inc. in July 2024. Vireo Growth Inc. was incorporated in 2004 and is headquartered in Minneapolis, Minnesota.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- Phone
- 612 999 1606
- Website
- https://vireogrowth.com
- Address
- 207 South 9th Street, Minneapolis, United States
Latest news
No headlines yet.
